搜索临床试验以:2.5IU/ml狂犬病疫苗(MRC-5细胞)21-60岁人群
总计2个结果
-
Beijing Center for Disease Control and PreventionBeijing Minhai Biotechnology Co., Ltd完全的健康 | 狂犬病
-
Beijing Center for Disease Control and PreventionBeijing Minhai Biotechnology Co., Ltd完全的安全性、免疫原性